Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

St. Jude Medical (STJ)

St. Jude Medical (STJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,054,430
  • Shares Outstanding, K 285,590
  • Annual Sales, $ 5,541 M
  • Annual Income, $ 880,000 K
  • 60-Month Beta 1.23
  • Price/Sales 3.90
  • Price/Cash Flow N/A
  • Price/Book 5.15
Trade STJ with:
  • Price/Earnings ttm 20.32
  • Earnings Per Share ttm 3.97
  • Most Recent Earnings 0.99 on 10/19/16
  • Next Earnings Date 01/25/17
  • Annual Dividend & Yield 1.24 (0.00%)
  • Most Recent Dividend 0.310 on 09/28/16
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/16
See More
  • Average Estimate 1.06
  • Number of Estimates 17
  • High Estimate 1.12
  • Low Estimate 1.02
  • Prior Year 1.02
  • Growth Rate Est. (year over year) +3.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.59 +2.84%
on 12/07/16
81.31 -0.60%
on 01/04/17
+1.80 (+2.28%)
since 12/02/16
3-Month
77.32 +4.53%
on 11/03/16
81.53 -0.87%
on 10/10/16
+0.99 (+1.24%)
since 10/04/16
52-Week
48.83 +65.51%
on 02/11/16
84.00 -3.79%
on 08/08/16
+20.42 (+33.81%)
since 01/04/16

Most Recent Stories

More News
Conformal Medical Appoints George Fazio to Board of Directors

, /PRNewswire/ -- , a privately-held medical device company developing next generation left atrial appendage closure (LAAC) technology, today announced the appointment of to its board of directors....

STJ : 80.82 (+0.16%)
Prosthetic Heart Valve Market Research Report by Type, by Sensor, by Technology, by End-use Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 109.27 (-1.46%)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
EW : 84.70 (+0.20%)
LIFE : 3.51 (+5.41%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
US Heart Valve Repair and Replacement Market: Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025

Heart Valve Repair and Replacement Market is valued at USD 6017.58 Million in 2018 and expected to reach USD 12104.80 Million by 2025 with the CAGR of 10.5% over the forecast period.

AORTF : 4.5223 (+0.63%)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
LIFE : 3.51 (+5.41%)
MDT : 110.97 (+0.74%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
Jim Dillon, Former St. Jude Medical Executive, Joins FAST BioMedical Board of Directors

, /PRNewswire/ -- , a privately held late clinical-stage medical technology company, today announces it has named to its Board of Directors. Dillon is a former St. Jude Medical and Abiomed executive,...

STJ : 80.82 (+0.16%)
UPDATE - InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a)

InspireMD, Inc. (NYSE American: NSPR) ("Company"), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces the...

NSPR : 0.3630 (+1.00%)
STJ : 80.82 (+0.16%)
InspireMD, Inc. Appoints Andrea Tommasoli Senior Vice President of Global Sales and Marketing and Reports Inducement Grants Under NYSE American Company Guide §711(a)

InspireMD, Inc. (NYSE American: NSPR) ("Company"), the developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces the...

NSPR : 0.3630 (+1.00%)
STJ : 80.82 (+0.16%)
Global Hygienic Pressure Sensor Market Trends and Research Insights by 2030| Baumer, SICK AG's company, ESI Technology

BAR.TO : 0.80 (-1.23%)
MDT : 110.97 (+0.74%)
PCRFY : 10.6950 (+0.85%)
STJ : 80.82 (+0.16%)
US Heart Valve Repair and Replacement Market Size | 2020, Growth Strategies, Opportunity, Challenges, Rising Trends and Revenue Analysis 2025

The delivers a succinct analysis on industry size, regional growth and revenue forecasts for the upcoming years. The report further sheds light on significant challenges and latest growth strategies adopted...

AORTF : 4.5223 (+0.63%)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
LIFE : 3.51 (+5.41%)
MDT : 110.97 (+0.74%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
Prosthetic Heart Valve Market Research Report by Type, by Offering, by Communication Protocol, by Industry - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.

ABT : 109.27 (-1.46%)
BSX : 33.33 (-1.10%)
CRY : 20.87 (+4.14%)
EW : 84.70 (+0.20%)
LIFE : 3.51 (+5.41%)
NVCN.TO : 1.14 (unch)
STJ : 80.82 (+0.16%)
Global Defibrillator (Implantable, External) Markets, 2015-2019 & 2020-2025

, /PRNewswire/ -- The report has been added to offering.

BSX : 33.33 (-1.10%)
LIVN : 51.03 (+2.72%)
MDT : 110.97 (+0.74%)
NHNKY : 16.5950 (+3.05%)
STJ : 80.82 (+0.16%)

Business Summary

St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology...

See More

Key Turning Points

2nd Resistance Point 81.54
1st Resistance Point 81.18
Last Price 80.82
1st Support Level 80.59
2nd Support Level 80.36

See More

52-Week High 84.00
Last Price 80.82
Fibonacci 61.8% 70.57
Fibonacci 50% 66.42
Fibonacci 38.2% 62.26
52-Week Low 48.83

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar